EE05268B1 - Perindopriili tert-butlamiinsoola kristalliline alfa-vorm, selle valmistamisprotsess ja seda sisaldavad farmatseutilised kompositsioonid - Google Patents

Perindopriili tert-butlamiinsoola kristalliline alfa-vorm, selle valmistamisprotsess ja seda sisaldavad farmatseutilised kompositsioonid

Info

Publication number
EE05268B1
EE05268B1 EEP200300001A EEP200300001A EE05268B1 EE 05268 B1 EE05268 B1 EE 05268B1 EE P200300001 A EEP200300001 A EE P200300001A EE P200300001 A EEP200300001 A EE P200300001A EE 05268 B1 EE05268 B1 EE 05268B1
Authority
EE
Estonia
Prior art keywords
laminate
salt
preparation
pharmaceutical compositions
compositions containing
Prior art date
Application number
EEP200300001A
Other languages
English (en)
Estonian (et)
Inventor
Pfeiffer Bruno
Ginot Yves-Michel
Coquerel G�rard
Beilles St�phane
Original Assignee
Les Laboratoires Servier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8852172&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE05268(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Les Laboratoires Servier filed Critical Les Laboratoires Servier
Publication of EE200300001A publication Critical patent/EE200300001A/xx
Publication of EE05268B1 publication Critical patent/EE05268B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
EEP200300001A 2000-07-06 2001-07-06 Perindopriili tert-butlamiinsoola kristalliline alfa-vorm, selle valmistamisprotsess ja seda sisaldavad farmatseutilised kompositsioonid EE05268B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0008793A FR2811320B1 (fr) 2000-07-06 2000-07-06 Nouvelle forme cristalline alpha du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
PCT/FR2001/002167 WO2001087835A1 (fr) 2000-07-06 2001-07-06 FORME CRISTALLINE α DU SEL DE TERT-BUTYLAMINE DU PERINDOPRIL

Publications (2)

Publication Number Publication Date
EE200300001A EE200300001A (et) 2004-08-16
EE05268B1 true EE05268B1 (et) 2010-02-15

Family

ID=8852172

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200300001A EE05268B1 (et) 2000-07-06 2001-07-06 Perindopriili tert-butlamiinsoola kristalliline alfa-vorm, selle valmistamisprotsess ja seda sisaldavad farmatseutilised kompositsioonid

Country Status (35)

Country Link
US (2) US20030186896A1 (es)
EP (1) EP1296947B1 (es)
JP (2) JP3602826B2 (es)
KR (1) KR100513570B1 (es)
CN (1) CN1328259C (es)
AP (1) AP1537A (es)
AR (1) AR034124A1 (es)
AT (1) ATE258918T1 (es)
AU (2) AU2001276418B2 (es)
BG (1) BG64868B1 (es)
BR (1) BR0112367A (es)
CA (1) CA2415438C (es)
CZ (1) CZ297672B6 (es)
DE (1) DE60101968T2 (es)
DK (1) DK1296947T3 (es)
EA (1) EA005008B1 (es)
EE (1) EE05268B1 (es)
ES (1) ES2214434T3 (es)
FR (1) FR2811320B1 (es)
GE (1) GEP20043361B (es)
HK (1) HK1055425A1 (es)
HR (1) HRP20030077B1 (es)
ME (1) ME00443B (es)
MX (1) MXPA02012949A (es)
NO (1) NO323447B1 (es)
NZ (1) NZ523173A (es)
OA (1) OA12304A (es)
PL (1) PL206359B1 (es)
PT (1) PT1296947E (es)
RS (1) RS50915B (es)
SK (1) SK285714B6 (es)
TR (1) TR200400238T4 (es)
UA (1) UA57188C2 (es)
WO (1) WO2001087835A1 (es)
ZA (1) ZA200210092B (es)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2811318B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline gamma du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2811319B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline beta du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2838648B1 (fr) * 2002-04-18 2004-05-21 Servier Lab Nouveau sel de perindopril et les compositions pharmaceutiques qui le contiennent
GB2395195A (en) 2002-11-18 2004-05-19 Cipla Ltd Preparation of perindopril from carboxy-protected precursor, & perindopril monohydrates for use as angiotensin converting enzyme (ACE) inhibitors
KR20060035636A (ko) * 2003-06-24 2006-04-26 르 라보레또레 쎄르비에르 신규한 결정형의 페린도프릴 에르부민
WO2005037788A1 (en) * 2003-10-21 2005-04-28 Lupin Ltd. Novel method for preparation of crystalline perindopril erbumine
SI21703A (en) 2004-01-14 2005-08-31 Lek Farmacevtska Druzba Dd Inclusion complexes of perindopril, procedure of their preparation, pharmaceutical compositions containing these complexes and their application in treatment of hypertensia
JP4948392B2 (ja) * 2004-03-29 2012-06-06 レ ラボラトア セルビエ 固形薬学的組成物を調製するためのプロセス
WO2005108365A1 (en) * 2004-05-07 2005-11-17 Glenmark Pharmaceuticals Limited Processes for the preparation of alpha polymorph of perindopril erbumine
US20050250706A1 (en) * 2004-05-07 2005-11-10 Glenmark Pharmaceuticals Limited Processes for the preparation of alpha polymorph of perindopril erbumine
SI21800A (sl) 2004-05-14 2005-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Nov postopek sinteze perindoprila
SI21881A (sl) 2004-10-15 2006-04-30 Diagen, Smartno Pri Ljubljani, D.O.O. Nove kristalne oblike perindopril erbumin hidratov, postopek za njihovo pripravo in farmacevtske oblike, ki vsebujejo te spojine
SG125975A1 (en) * 2005-03-11 2006-10-30 Servier Lab New alpha crystalline form of perindopril tert-butylamine salt, a process for its preparation and pharmaceutical compositions containing it
SG125976A1 (en) * 2005-03-11 2006-10-30 Servier Lab New gama crystalline form of perindopril tert-butylamine salt, a process for its preparation and pharmaceutical compositions containing it
JP2006290825A (ja) * 2005-04-13 2006-10-26 Shiono Chemical Co Ltd アルファ型ペリンドプリルエルブミンの製造法
WO2007017894A2 (en) * 2005-05-05 2007-02-15 Arch Pharmalabs Limited PREPARATION OF NOVEL CRYSTALLINE η(ETA) FORM OF PERINDOPRIL ERBUMINE
US20070032661A1 (en) * 2005-08-03 2007-02-08 Glenmark Pharmaceuticals Limited Process for the preparation of intermediates of perindopril
MX2008002066A (es) * 2005-08-12 2008-04-16 Sandoz Ag Neuva forma cristalina de perindopril-erbumina.
AU2006281684B2 (en) * 2005-08-12 2012-08-02 Lek Pharmaceuticals D.D. A process for the preparation of perindopril erbumine
EP1815857A1 (en) 2006-02-02 2007-08-08 LEK Pharmaceuticals D.D. A pharmaceutical composition comprising perindopril
WO2007092758A2 (en) * 2006-02-03 2007-08-16 Dr. Reddy's Laboratories Ltd. Crystalline forms of perindopril erbumine
FR2897865B1 (fr) * 2006-02-28 2008-04-18 Servier Lab Forme cristalline beta du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2897866B1 (fr) * 2006-02-28 2008-04-18 Servier Lab Forme cristalline alpha du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
EA200600630A1 (ru) * 2006-04-20 2007-02-27 ИСМАГИЛОВ, Искандар Халиуллович ζ-ЗЕТА ФОРМА ПЕРИНДОПРИЛ ЭРБУМИНА
EP1964836A3 (en) * 2006-11-06 2008-11-19 IPCA Laboratories Limited A process for the preparation of perindopril erbumine in alpha crystalline form
GB0624084D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril amino acid salts
GB0624090D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril amine salts
GB0624087D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril combination salt
EP2137148A1 (en) * 2007-03-22 2009-12-30 Aarti Healthcare Limited Process for the preparation of perindopril erbumine salt and novel polymorph (s) thereof
WO2008120241A2 (en) * 2007-03-29 2008-10-09 Ipca Laboratories Limited Novel alcohol solvates of perindopril erbumine
AU2013201812B2 (en) * 2007-06-27 2015-04-02 Les Laboratoires Servier Salts of perindopril
SI22543A (sl) 2007-06-27 2008-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Nove soli perindoprila
SI23149A (sl) 2009-09-21 2011-03-31 Silverstone Pharma Nove benzatinske soli ACE inhibitorjev, postopek za njihovo pripravo in njihova uporaba za zdravljenje kardiovaskularnih bolezni
PT105315B (pt) 2010-09-29 2013-01-16 Inst Superior Tecnico Uma nova forma cristalina hidratada de erbumina de perindopril, métodos para a sua preparação e sua utilização em preparações farmacêuticas
CN103822996A (zh) * 2014-03-20 2014-05-28 东英（江苏）药业有限公司 一种培哚普利叔丁胺盐含量的测定方法
CN105395497B (zh) * 2015-12-04 2019-06-18 杭州新诺华医药有限公司 一种稳定的α晶型培哚普利叔丁胺片及制备方法
EP3842035A1 (en) 2019-12-23 2021-06-30 KRKA, d.d., Novo mesto Composition for the preparation of perindopril arginine granules, a method for their preparation and pharmaceutical composition comprising the granules

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2503155A2 (fr) * 1980-10-02 1982-10-08 Science Union & Cie Nouveaux imino diacides substitues, leurs procedes de preparation et leur emploi comme inhibiteur d'enzyme
FR2620744A1 (fr) * 1987-09-17 1989-03-24 Degremont Procede de traitement par l'ozone de materiaux ligno-cellulosiques, notamment de pates a papier et reacteur pour la mise en oeuvre de ce procede
FR2620709B1 (fr) * 1987-09-17 1990-09-07 Adir Procede de synthese industrielle du perindopril et de ses principaux intermediaires de synthese
FR2620703B1 (fr) * 1987-09-17 1991-10-04 Adir Procede de synthese industrielle de l'acide perhydroindole carboxylique - 2(2s, 3as, 7as). application a la synthese de carboxyalkyl dipeptides
FR2771010B1 (fr) * 1997-11-19 2003-08-15 Adir Utilisation d'une combinaison d'un inhibiteur de l'enzyme de conversion de l'angiotensine et d'un diuretique pour le traitement des desordres microcirculatoires
FR2811318B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline gamma du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2811319B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline beta du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent

Also Published As

Publication number Publication date
EA200300107A1 (ru) 2003-06-26
NO323447B1 (no) 2007-05-07
AP1537A (en) 2006-01-10
WO2001087835A1 (fr) 2001-11-22
KR20030024773A (ko) 2003-03-26
ZA200210092B (en) 2003-12-12
NZ523173A (en) 2004-04-30
EE200300001A (et) 2004-08-16
ATE258918T1 (de) 2004-02-15
CZ2003357A3 (cs) 2003-05-14
CA2415438C (fr) 2009-01-20
CN1440387A (zh) 2003-09-03
TR200400238T4 (tr) 2004-03-22
SK1492003A3 (en) 2003-06-03
US20030186896A1 (en) 2003-10-02
EP1296947B1 (fr) 2004-02-04
SK285714B6 (sk) 2007-06-07
AP2002002691A0 (en) 2002-12-31
EA005008B1 (ru) 2004-10-28
KR100513570B1 (ko) 2005-09-09
UA57188C2 (uk) 2003-06-16
CN1328259C (zh) 2007-07-25
ME00443B (me) 2011-10-10
HRP20030077B1 (en) 2011-07-31
YU100402A (sh) 2003-08-29
JP2003533507A (ja) 2003-11-11
ES2214434T3 (es) 2004-09-16
FR2811320A1 (fr) 2002-01-11
JP5016185B2 (ja) 2012-09-05
GEP20043361B (en) 2004-06-10
HK1055425A1 (en) 2004-01-09
JP2005047902A (ja) 2005-02-24
DE60101968D1 (de) 2004-03-11
JP3602826B2 (ja) 2004-12-15
NO20030024L (no) 2003-01-03
OA12304A (en) 2003-12-29
BG64868B1 (bg) 2006-07-31
DK1296947T3 (da) 2004-06-01
FR2811320B1 (fr) 2002-08-23
HRP20030077A2 (en) 2003-04-30
PL348492A1 (en) 2002-01-14
US20050059609A1 (en) 2005-03-17
EP1296947A1 (fr) 2003-04-02
AR034124A1 (es) 2004-02-04
PL206359B1 (pl) 2010-07-30
BR0112367A (pt) 2003-05-13
MXPA02012949A (es) 2003-05-15
AU7641801A (en) 2001-11-26
NO20030024D0 (no) 2003-01-03
RS50915B (sr) 2010-08-31
AU2001276418B2 (en) 2005-07-28
BG107532A (en) 2003-12-31
DE60101968T2 (de) 2004-12-23
CA2415438A1 (fr) 2001-11-22
PT1296947E (pt) 2004-05-31
CZ297672B6 (cs) 2007-02-28

Similar Documents

Publication Publication Date Title
EE05268B1 (et) Perindopriili tert-butlamiinsoola kristalliline alfa-vorm, selle valmistamisprotsess ja seda sisaldavad farmatseutilised kompositsioonid
EE05286B1 (et) Perindopriili tert-butlamiinsoola kristalliline kamma-vorm, protsess selle valmistamiseks ning seda sisaldavad farmatseutilised kompositsioonid
EE05285B1 (et) Perindopriili tert-butlamiinsoola kristalliline β-vorm, protsess selle valmistamiseks ja seda sisaldavad farmatseutilised kompositsioonid
PL396568A1 (pl) Krystaliczny bursztynian O-demetylo-wenlafaksyny, kompozycja farmaceutyczna, farmaceutyczna postać dawkowania, doustna postać dawkowania, zastosowanie oraz sposób wytwarzania krystalicznego bursztynianu O-demetylo-wenlafaksyny
HUP0302519A3 (en) Crystalline forms of atorvastatin, process for their preparation and pharmaceutical compositions containing them
IL163831A (en) Derivatives of aminoindazoles, pharmaceutical compositions comprising them, process for their preparation and use thereof
EE200100318A (et) Kinoliini derivaat, selle ühendi kasutamine ravimina, seda sisaldav farmatseutiline kompositsioon ning meetod ühendi ja kompositsiooni valmistamiseks
AU2001276420A1 (en) Novel gamma crystalline form of perindopril tert-butylamine salt, preparation method, and pharmaceutical compositions containing same.
HUP0401141A3 (en) Crystalline forms of fluvastatin sodium, process for their preparation and pharmaceutical compositions containing them
AU2003222921A1 (en) Novel perindopril salt and pharmaceutical compositions containing same
EE05242B1 (et) 5-kloro-3-(4-metaansulfonlfenl)-6'-metl[2,3']bipridinli polmorfne vorm, selle valmistamismeetod, kasutamine ja farmatseutiline kompositsioon
HUP0401747A3 (en) Piridazine derivatives of hydrazono-malonitriles, their use, process for preparation of the compounds and pharmaceutical compositions containing the compounds
HUP0300231A3 (en) Process for the preparation of high purity perindopril and intermediates useful in the synthesis, pharmaceutical compositions containing the compound and their use
EE200100662A (et) Hüübimistegurit pärssiv ühend, meetod selle valmistamiseks, seda sisaldav farmatseutiline preparaatning raviotstarbeline kasutamine
EE200400022A (et) Pürrolidiinoksadiasooli ja -tiadiasooli derivaadid, nende valmistamise meetod ja neid sisaldavad ravimkoostised
EE200400018A (et) Gatifloksatsiini ja rasvhappe kristalne kopretsipitaat, selle valmistamise meetod ja seda sisaldav ravimkoostis
HUP0303105A3 (en) Novel aminocyclohexane derivatives, process for their preparation, pharmaceutical compositions containing them and their use
HUP0300248A3 (en) Amino acid derivatives and use thereof as nep, ace and ece inhibitors, process for their preparation and pharmaceutical compositions containing them
EE200300548A (et) Uudsed 5-tio-ß-D-ksülopüranosiidi derivaadid, nende valmistamise meetod, neid sisaldavad farmatseutilised kompositsioonid ja nende terapeutiline kasutamine
EE200400007A (et) Fenüületanoolamiini kristallivorm, selle valmistamine ja seda sisaldavad farmatseutilised kompositsioonid
EE200200528A (et) 2-fenüülpüran-4-ooni derivaat, meetod selle valmistamiseks, seda sisaldav farmatseutiline kompositsioon ning ühendi ja kompositsiooni raviotstarbeline kasutamine
HUP0102815A3 (en) New alpha crystalline form of perindopril tert-butylamine salt, process for its preparation and pharmaceutical compositions containing it
SI1348704T1 (sl) Indolni derivati kot antagonisti 5-ht2c, postopekpriprave le teh in farmacevtski sestavki, ki jih vsebujejo
HU1000441D0 (en) Substituted alkylpyridazone derivatives, process for their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
HE1A Change of address
KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20180706